Tobacco and Oral Health
On this page
Direct answer
Roughly every fourth Indian adult — 28.6% in GATS 2016–17, about 267 million people — uses tobacco, and uniquely among large countries the smokeless forms dominate: 21.4% chew against 10.7% who smoke. The dental chair therefore sits at the country's best screening point for tobacco harm: staining, smoker's palate, leukoplakia and oral submucous fibrosis announce themselves in the mouth years before cancer does, and a brief chairside intervention structured on the 5 As — ask, advise, assess, assist, arrange — plus knowledge of COTPA 2003 converts every dentist into both a cessation worker and, in the exam, a prepared candidate.
What you must remember
- GATS India 2016–17: overall use 28.6% (down from 34.6% in 2009–10), smokeless 21.4%, smoked 10.7%, average age of initiation about 18–19 years.
- Indian products to name in vivas: bidi, cigarette; smokeless — gutkha, khaini, zarda, paan with tobacco, and mishri used as tooth powder.
- Mucosal changes: tobacco-associated keratosis and leukoplakia, nicotinic stomatitis (smoker's palate, fissured and umbilicated papules), staining, black hairy tongue, dose-dependent periodontal destruction, and delayed wound healing.
- Oral submucous fibrosis is driven by areca nut (arecoline, tannins) as much as by tobacco — gutkha combines both, and OSMF presents with burning, blanching, stiff mucosa, fibrotic bands and progressive trismus in a young user.
- Potentially malignant disorders in order of transformation risk: erythroplakia highest, then non-homogeneous (speckled, verrucous, nodular) leukoplakia over homogeneous; an ulcer or lesion not healing in two to three weeks demands referral for biopsy.
- Cessation pharmacotherapy: nicotine replacement (gum, patch, lozenge — gum 2 mg if first use is more than 30 minutes after waking, 4 mg otherwise), bupropion, varenicline; the national tobacco quitline 1800-11-2356 supports counselling.
- Law: COTPA 2003 — smoking banned in public places (section 4), sale to and by minors and within 100 yards of educational institutions banned (section 5), trade regulation (section 6), and 85% pictorial warnings on packs since 2016 (section 7); electronic cigarettes were prohibited by a separate 2019 Act, and states ban gutkha under food safety law.
A chairside cessation consult worked through
Apply the 5 As to a 35-year-old who chews khaini ten times daily and has a white patch on his buccal mucosa. Ask: "Do you or did you use tobacco?" — documented at every visit, the step most often skipped. Advise: show him the lesion in a hand mirror and say, in one clear sentence, that chewing is causing this change and quitting now allows most lesions to regress; a visible lesion is the strongest cue to action a dentist owns. Assess dependence: ten pouches a day, first chew within half an hour of waking — high dependence, so pharmacotherapy is appropriate. Assist: set a quit date within two weeks, switch him to 4 mg nicotine gum on the time-to-first-use rule, rehearse triggers (post-meal, workplace breaks) with substitutes, and enlist a family member. Arrange follow-up at one to two weeks for support and gum tolerability, and review the patch at two to three weeks — persistence beyond that window is the referral trigger for biopsy, not more watching. Run honestly, this five-minute protocol is the community dentistry answer to the question the whole subject exists for.
Where students slip
Two slips repeat. First, attributing oral submucous fibrosis to tobacco alone: examiners expect areca nut — arecoline stimulates fibroblast collagen and impairs its breakdown — with gutkha's tobacco-plus-areca combination the typical culprit, and the trismus-progressing young patient the classic case. Second, writing "stop tobacco" as the entire cessation answer: the marks sit in the structure — 5 As for the willing, 5 Rs (relevance, risks, rewards, roadblocks, repetition) for the unwilling, and a named pharmacological option with its dosing logic. Law answers also thin out fast: candidates know COTPA exists but cannot attach section numbers to the public-place smoking ban or the 100-yard school rule, and they miss that the gutkha ban operates through food safety legislation treating tobacco-nicotine as prohibited food ingredients, not through COTPA at all. The "safe smokeless" myth deserves an explicit rebuttal in the exam: smokeless is not safe, merely differently lethal.
Frequently asked questions
What were the key GATS India 2016-17 findings?
28.6% of adults use tobacco — about 267 million people — with smokeless use (21.4%) double smoked use (10.7%), and average initiation in the late teens.
Which oral lesion has the highest malignant transformation potential?
Erythroplakia carries the highest risk, exceeding non-homogeneous leukoplakia, which in turn exceeds the homogeneous variety.
What are the 5 As of brief tobacco intervention?
Ask about tobacco use at every visit, advise quitting clearly, assess willingness and dependence, assist with a quit plan and pharmacotherapy, and arrange follow-up.
Which statute regulates tobacco products in India?
The Cigarettes and Other Tobacco Products Act, 2003, covering public-place smoking, sales to minors and near institutions, trade regulation and mandatory pictorial warnings.
Why does oral submucous fibrosis figure in tobacco counselling?
Because gutkha and similar products combine tobacco with areca nut, whose arecoline drives fibrosis, making OSMF a visible, preventable precursor condition in young chewers.